JNJ: Leadership change

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026. The Company’s related press release is attached to this Report as Exhibit 99.1. Item 9.01 Financial statements and exhibits (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press Release dated August 4, 2026 . 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 4, 2026 JOHNSON & JOHNSON (Registrant) By: /s/ Marc Larkins Marc Larkins Corporate Secretary